1CM Inc. announced that it has entered into a Business Collaboration Agreement with Herbidus Formulations Pvt Ltd. The scope of collaboration includes licensing 1CM Inc.'s brands to the Trost for its manufacturing of Cannabis Ayurvedic Herbal Cigarettes ("Rollen" or "pre-rolls"), and the establishment of 2 Ayurvedic Medicine Flagship Clinics. If Trost can achieve the milestones set out in the Business Collaboration Agreement, and pending all regulatory approval, 1CM Inc. will have the ability to purchase the Trost based on a predetermined valuation formula not to exceed an enterprise value of INR 50,00,00,000 (App Approximately. CAD 8,337,815).

The Trost currently purchases all cannabis flower from the Government of Uttar Pradesh, Department of Excise ("Abkari") and licensed by Ministry of Ayush, Government of India. The Trost currently has a quota, which allows it to purchase up to 16,000kg of Cannabis flower leaf annually directly from the government for manufacturing into pre-rolls. The cannabis flower leaf is processed by maintaining the full profile of the plant and is permitted to contain naturally occurring amounts of THC, CBD, CBN and CBG.

1CM Inc. intends to provide its expertise to develop its cannabis stream and distribution in India. India is expected to become the most populous country in the world in 2023. This new enterprise provides a entry for 1CM into India with an existing domestic licensed ayurvedic medicine cannabis operator.